The medtech company Vibrosense Dynamics has made significant progress on several fronts as the international launch of Vibrosense Meter II has been ramped up during the autumn.The company points to progress from contacts with potential distributors to research within the segments prioritized by Vibrosense, diabetes, oncology and occupational health.The strategy for Europe and Asia has been updated and the business model has been adjusted so that the company can meet new requirements and needs in the market. While the focus in Europe is on sales to end customers and research projects, in Asia the emphasis is on distributors. "A comprehensive market outreach has been initiated with the support of AI-based systems for lead generation and identification of potential customers. In a short time, the company has built up a larger database of contacts, which has resulted in a large number of customer meetings during the autumn," it says. The launch is expected to continue at an unchanged pace without the need for additional financing.